February 6, 2020
Tomiko Tawaragi, Chief Director, RAD-AR RAD-AR (Risk/Benefit Assessment of Drugs-Analysis and Response) Council, Japan, a group of major pharmaceutical companies that promotes the proper use of medicines, is accelerating its initiative to prepare drug information sheets for ethical drugs in...read more